Amgen (AMGN): FY24 Q4 earnings call, Feb 4, 2025

Tue, Feb 4Earnings callSpeaker-labelled transcriptAmgen

No Kalshi or Polymarket word markets were listed for Amgen’s Feb 4, 2025 earnings call (FY24 Q4). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

3 matches for “Oral”; 3 quoted, at least 25 words apart.

Courtney Breenanalystqa

…of how you anticipate this market evolving as we think about the oral PCSK9s and Merck's CORALreef lipids trial that is also scheduled to read…

Murdo Gordoncompanyqa

…what the evidence is and how it accumulates with not just the orals, but other competitors that are trying to come into this market. But…

Michael Yeeanalystqa

…confident on MariTide, given that everyone's chasing a multiple asset portfolio, including orals, and you seem to be pretty early stage outside of MariTide. So…

Agents: this page as TSV at /api/v1/appearances/amgen:2025-02-04:earnings_call · words: /api/v1/brief?appearance=amgen:2025-02-04:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP